OS Therapies Incorporated (OSTX)

OS Therapies will go public soon, but the exact IPO date is still unknown.

IPO Price

$5.00

Shares Offered

2,000,000

Deal Size

$10.00M

OS Therapies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021
Selling, General & Admin	1.15	1.5
Research & Development	3.29	2.17
Other Operating Expenses	0	1.16
Operating Expenses	4.45	4.84
Operating Income	-4.45	-4.84
Interest Expense / Income	1.81	2.58
Pretax Income	-6.38	-7.51
Net Income	-6.25	-7.42
Preferred Dividends	0.13	0.09
Net Income Common	-6.38	-7.51
Free Cash Flow	-3.79	-4.41
EBITDA	-3.42	-2.86
Depreciation & Amortization	1.15	2.07
EBIT	-4.57	-4.93

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).